Status:
UNKNOWN
CellAdhesionMolecule EndometriosisRatio - CAMERA
Lead Sponsor:
Heinrich Husslein
Collaborating Sponsors:
Medical-Scientific Fund of the Mayor of the Federal Capital Vienna
Conditions:
Endometriosis (Diagnosis)
Identification of Biomarkers in Serum
Eligibility:
FEMALE
18-50 years
Brief Summary
Background: Endometriosis, which is characterized by the growth of endometrial stroma and glands outside of the uterine cavity, is estimated to occur in 6-10% of women of reproductive age. Clinical pr...
Eligibility Criteria
Inclusion
- unfulfilled desire for children
- chronic pelvic pain
- suspicion of endometriosis
- cysts
- myomas
Exclusion
- acute infections
- malign diseases
- drug abuse
- pregnancy
- infectious diseases
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04294017
Start Date
November 1 2017
End Date
December 31 2022
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Vienna
Vienna, Austria